Journal article
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Abstract
A correction to this paper has been published: https://doi.org/10.1007/s00277-021-04545-5
Authors
Heuser M; Smith BD; Fiedler W; Sekeres MA; Montesinos P; Leber B; Merchant A; Papayannidis C; Pérez-Simón JA; Hoang CJ
Journal
Annals of Hematology, Vol. 100, No. 7, pp. 1917–1918
Publisher
Springer Nature
Publication Date
July 2021
DOI
10.1007/s00277-021-04545-5
ISSN
0939-5555